1. Home
  2. VERU vs INTT Comparison

VERU vs INTT Comparison

Compare VERU & INTT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VERU
  • INTT
  • Stock Information
  • Founded
  • VERU 1971
  • INTT 1981
  • Country
  • VERU United States
  • INTT United States
  • Employees
  • VERU N/A
  • INTT N/A
  • Industry
  • VERU Biotechnology: Pharmaceutical Preparations
  • INTT Semiconductors
  • Sector
  • VERU Health Care
  • INTT Technology
  • Exchange
  • VERU Nasdaq
  • INTT Nasdaq
  • Market Cap
  • VERU 85.5M
  • INTT 89.8M
  • IPO Year
  • VERU 1990
  • INTT 1997
  • Fundamental
  • Price
  • VERU $3.45
  • INTT $7.25
  • Analyst Decision
  • VERU Strong Buy
  • INTT Strong Buy
  • Analyst Count
  • VERU 3
  • INTT 2
  • Target Price
  • VERU $33.33
  • INTT $12.00
  • AVG Volume (30 Days)
  • VERU 139.0K
  • INTT 51.3K
  • Earning Date
  • VERU 08-12-2025
  • INTT 10-31-2025
  • Dividend Yield
  • VERU N/A
  • INTT N/A
  • EPS Growth
  • VERU N/A
  • INTT N/A
  • EPS
  • VERU N/A
  • INTT N/A
  • Revenue
  • VERU $16,886,419.00
  • INTT $121,642,000.00
  • Revenue This Year
  • VERU N/A
  • INTT N/A
  • Revenue Next Year
  • VERU N/A
  • INTT $10.38
  • P/E Ratio
  • VERU N/A
  • INTT N/A
  • Revenue Growth
  • VERU 337.24
  • INTT N/A
  • 52 Week Low
  • VERU $2.64
  • INTT $5.24
  • 52 Week High
  • VERU $14.20
  • INTT $9.77
  • Technical
  • Relative Strength Index (RSI)
  • VERU 42.63
  • INTT 53.40
  • Support Level
  • VERU $3.24
  • INTT $7.08
  • Resistance Level
  • VERU $3.94
  • INTT $7.31
  • Average True Range (ATR)
  • VERU 0.22
  • INTT 0.29
  • MACD
  • VERU 0.10
  • INTT 0.02
  • Stochastic Oscillator
  • VERU 31.94
  • INTT 50.66

About VERU Veru Inc.

Veru Inc is a biopharmaceutical company with a drug development program for the treatment of metabolic diseases, oncology, and acute respiratory distress syndrome (ARDS). The company is also in the late-stage development of certain drugs for the management of breast and prostate cancers. It also has a sexual health program that includes two products, ENTADFI, for the treatment of benign prostatic hyperplasia (BPH) and the FC2 Female Condom (Internal Condom). The company operates in a single segment and generates revenue from the USA which is the key revenue generating market, Brazil, and other regions.

About INTT inTest Corporation

inTest Corp is a supplier of test and process solutions for use in manufacturing and testing across a range of markets including automotive, defense/aerospace, industrial, medical, semiconductor and telecommunications. The company manages its business as three operating segments which is also their reporting units that includes Electronic Test, Environmental Technologies and Process Technologies. Electronic Test (which includes semiconductor test equipment, flying probe and in-circuit testers), Environmental Technologies (which includes its thermal test, process and storage products) and Process Technologies (which includes induction heating and video imaging products). The company operates their business and sells its products both domestically and internationally.

Share on Social Networks: